Voiding dysfunction in benign prostatic hyperplasia: trends, controversies and recent revelations. II. Pathology and pathophysiology.
Elbadawi
A
A
State University of New York, Health Science Center, Department of Pathology, Syracuse 13210, USA.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D003094:Collagen / Q000378:metabolism; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D014524:Urethral Obstruction / Q000503:physiopathology; D001743:Urinary Bladder / Q000503:physiopathology / Q000648:ultrastructure
D000317:Adrenergic alpha-Antagonists; D003094:Collagen